Savings bonanza

piggy bank, money and calculator

What’s being targeted in the 1 October PBS price cuts?

More than 2,000 medicine brands will be reduced in price for non-concessional patients in the 1 October wave of PBS price reductions.

Some leading brands will see their price reduced by as much as $20 per script, according to information released today by the Department of Health.

Among highly prescribed medicines, Irbesartan with hydrochlorothiazide is set to be reduced by 20%, while the price of rosuvastatin will decrease by more than 14%. Both telmisartan and atorvastatin will see their price drop by more than 12%.

Irbesartan, venlafaxine and duloxetine are all set to also drop in price by more than 10% from the 1 October. Click here for the list of cuts affecting the 20 most prescribed medicines.

Below is a list of the 10 biggest savings for non-concessional patients from 1 October 2016.

The savings for these medicines may vary depending on a number of factors such as formulation and strength, brand, the concessional status of the patient and any discretionary fees added or discounting by the pharmacist.

Drug name

$ savings per script

% savings per script

Alendronic acid with colecalciferolUp to $23.37Up to 61.02%
Alendronic acid with colecalciferol and calciumUp to $23.37Up to 61.02%
CefalotinUp to $13.27Up to 34.65%
MethotrexateUp to $10.91Up to 28.49%
Fosinopril with hydrochlorothiazideUp to $10.63Up to 35.92%
Enalapril with hydrochlorothiazide   Up to $10.06Up to 37.66%
FlucloxacillinUp to $8.29Up to 30.58%
TemozolomideUp to $6.93Up to 22.54%
PioglitazoneUp to $6.72Up to 18.52%
DonepezilUp to $6.60Up to 22.40%

Click here for more information on the 1 October price cuts

Previous Controversial vaccination film pulled from festival
Next Research Roundup

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

No Comment

Leave a reply